Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Nasal Polyps
|
disease |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
484
|
34
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Moyamoya disease 1
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
92
|
50
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Total iron binding capacity function
|
phenotype |
|
Clinical Attribute
|
20
|
35
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Adult onset asthma
|
disease |
|
Disease or Syndrome
|
48
|
67
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Fasting blood sugar result
|
phenotype |
|
Laboratory or Test Result
|
65
|
113
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Fatty acid measurement
|
group |
|
Laboratory Procedure
|
50
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Iron binding capacity total measurement
|
phenotype |
|
Laboratory Procedure
|
20
|
35
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.100 |
None |
1.000 |
1 |
6
|
2018 |
2018 |
Arachidonic acid measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Phospholipid measurement
|
phenotype |
|
Laboratory Procedure
|
58
|
306
|
0.100 |
None |
1.000 |
1 |
16
|
2011 |
2011 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Respiratory Tract Diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
198
|
109
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Ankylosing spondylitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
710
|
609
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Kidney Failure, Chronic
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
827
|
425
|
0.100 |
None |
1.000 |
1 |
6
|
2018 |
2018 |
Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
188
|
276
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1458
|
827
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Moyamoya Disease
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
117
|
50
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |